Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Op Grant: Data Analysis - Reproductive, Maternal, Child and Youth Health

University of British Columbia

$75,000.00

Health and developmental trajectories of infants born with Neonatal Abstinence Syndrome: sex differences and implications for harm reduction

FY 2019-20

Summary
Exposure to opioids during pregnancy can have negative effects on baby's development, including preterm birth, slow fetal growth, and neonatal abstinence syndrome. Neonatal abstinence syndrome is a drug withdrawal syndrome occurring shortly after birth and affecting baby's sleep, feeding and nervous system function. Our previous research showed that neonatal abstinence syndrome increased in Canada from 2.0 to 5.1 per 1000 live births between 2005 and 2015, and that the affected babies have high occurrence of severe neonatal morbidity. Data from Ontario suggest a 16-fold increase in mothers affected by opioid dependence between 2002 and 2014, with the hospital cost rising from $724,774 to $10,539,988 per year. However, very little is known about long-term effects of neonatal abstinence syndrome on childhood health and development. Our first objective is to examine health trajectories among children born with neonatal abstinence syndrome in British Columbia between 2001/02 and 2017/18 in a follow-up period of up to 18 years. Secondly, we will assess developmental vulnerability among these children and thirdly, we will look at potential differences in these outcomes and risk factors between boys and girls. We will utilize data on all births from the BC Perinatal Database Registry including information on pregnancy and childbirth complications and other clinical and demographic characteristics. Follow-up data will be obtained from children's hospitalization records and developmental assessments in kindergarten, which can be linked to the Perinatal Database. Any information that could potentially identify individual children will not be released for confidentiality reasons. In the light of the ongoing opioid crisis, our goal is to provide information on determinants of early childhood morbidity and developmental vulnerability among children born with neonatal abstinence syndrome. Our results will help to create optimal targets for harm reduction and prevention.
Program
Op Grant: Data Analysis - Reproductive, Maternal, Child and Youth Health
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
421846
Name
Lisonkova Sarka
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
Data Analysis Using Existing Databases and Cohorts
Projecttitle
Health and developmental trajectories of infants born with Neonatal Abstinence Syndrome: sex differences and implications for harm reduction
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$75,000
Cihrequipment2
$0
Programname2
Op Grant: Data Analysis - Reproductive, Maternal, Child and Youth Health
Keyworddelim
Developmental Vulnerabililty; Follow-Up; Health Trajectory; Neonatal Abstinence Syndrome
Abstract
Exposure to opioids during pregnancy can have negative effects on baby's development, including preterm birth, slow fetal growth, and neonatal abstinence syndrome. Neonatal abstinence syndrome is a drug withdrawal syndrome occurring shortly after birth and affecting baby's sleep, feeding and nervous system function. Our previous research showed that neonatal abstinence syndrome increased in Canada from 2.0 to 5.1 per 1000 live births between 2005 and 2015, and that the affected babies have high occurrence of severe neonatal morbidity. Data from Ontario suggest a 16-fold increase in mothers affected by opioid dependence between 2002 and 2014, with the hospital cost rising from $724,774 to $10,539,988 per year. However, very little is known about long-term effects of neonatal abstinence syndrome on childhood health and development. Our first objective is to examine health trajectories among children born with neonatal abstinence syndrome in British Columbia between 2001/02 and 2017/18 in a follow-up period of up to 18 years. Secondly, we will assess developmental vulnerability among these children and thirdly, we will look at potential differences in these outcomes and risk factors between boys and girls. We will utilize data on all births from the BC Perinatal Database Registry including information on pregnancy and childbirth complications and other clinical and demographic characteristics. Follow-up data will be obtained from children's hospitalization records and developmental assessments in kindergarten, which can be linked to the Perinatal Database. Any information that could potentially identify individual children will not be released for confidentiality reasons. In the light of the ongoing opioid crisis, our goal is to provide information on determinants of early childhood morbidity and developmental vulnerability among children born with neonatal abstinence syndrome. Our results will help to create optimal targets for harm reduction and prevention.
Competitiondate
201910
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lisonkova, Sarka
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Human Dev &Child &Yth~ $75,000~ $0~
University of British Columbia - $75,000 Grant (2019-… | Canada Spends